Literature DB >> 33387212

Fecal microbiota transplantation for membranous nephropathy.

Guanzhou Zhou1,2, Jiaqi Zeng1,2, Lihua Peng1, Lei Wang1, Wei Zheng3, Yunsheng Yang4.   

Abstract

Membranous nephropathy is a pathological type of nephrotic syndrome. Current treatments including supportive therapy, corticosteroids, immunosuppressive agents are not effective for all patients. New therapies are needed to treat the disease safely and effectively. Gut microbiota may contribute to the pathogenesis of this disease. Fecal microbiota transplantation (FMT) has made achievements in many diseases. Here, we report a case in which FMT is used to treat a patient with membranous nephropathy and chronic diarrhea, whose symptoms ameliorated and renal function improved.

Entities:  

Keywords:  Fecal microbiota transplantation; Gut microbiota; Membranous nephropathy

Year:  2021        PMID: 33387212     DOI: 10.1007/s13730-020-00560-z

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  10 in total

1.  Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.

Authors:  Fernando C Fervenza; Gerald B Appel; Sean J Barbour; Brad H Rovin; Richard A Lafayette; Nabeel Aslam; Jonathan A Jefferson; Patrick E Gipson; Dana V Rizk; John R Sedor; James F Simon; Ellen T McCarthy; Paul Brenchley; Sanjeev Sethi; Carmen Avila-Casado; Heather Beanlands; John C Lieske; David Philibert; Tingting Li; Lesley F Thomas; Dolly F Green; Luis A Juncos; Lada Beara-Lasic; Samuel S Blumenthal; Amy N Sussman; Stephen B Erickson; Michelle Hladunewich; Pietro A Canetta; Lee A Hebert; Nelson Leung; Jay Radhakrishnan; Heather N Reich; Samir V Parikh; Debbie S Gipson; Dominic K Lee; Bruno R da Costa; Peter Jüni; Daniel C Cattran
Journal:  N Engl J Med       Date:  2019-07-04       Impact factor: 91.245

2.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

Review 3.  The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery.

Authors:  Anne-Els van de Logt; Maryline Fresquet; Jack F Wetzels; Paul Brenchley
Journal:  Kidney Int       Date:  2019-08-12       Impact factor: 10.612

Review 4.  Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease.

Authors:  M N Quraishi; W Shaheen; Y H Oo; T H Iqbal
Journal:  Clin Exp Immunol       Date:  2019-11-27       Impact factor: 4.330

5.  Rituximab in idiopathic membranous nephropathy.

Authors:  Piero Ruggenenti; Paolo Cravedi; Antonietta Chianca; Annalisa Perna; Barbara Ruggiero; Flavio Gaspari; Alessandro Rambaldi; Maddalena Marasà; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 10.121

Review 6.  Primary Membranous Nephropathy.

Authors:  William G Couser
Journal:  Clin J Am Soc Nephrol       Date:  2017-05-26       Impact factor: 8.237

7.  [A pilot study of treating ulcerative colitis with fecal microbiota transplantation].

Authors:  Rongrong Ren; Gang Sun; Yunsheng Yang; Lihua Peng; Xiuli Zhang; Shufang Wang; Yan Dou; Xiaomei Zhang; Zikai Wang; Xiaochen Bo; Qingsen Liu; Wen Li; Nannan Fan; Xin Ma
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2015-05

Review 8.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 9.  Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components.

Authors:  Mateo Ondrussek-Sekac; Diana Navas-Carrillo; Esteban Orenes-Piñero
Journal:  Crit Rev Food Sci Nutr       Date:  2020-05-12       Impact factor: 11.176

10.  The Effect of Fecal Microbiota Transplantation on a Child with Tourette Syndrome.

Authors:  Huijun Zhao; Yichao Shi; Xi Luo; Lihua Peng; Yunsheng Yang; Liping Zou
Journal:  Case Rep Med       Date:  2017-12-12
  10 in total
  4 in total

Review 1.  Faecal Microbiota Transplantation and Chronic Kidney Disease.

Authors:  Ji Bian; Ann Liebert; Brian Bicknell; Xin-Ming Chen; Chunling Huang; Carol A Pollock
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

2.  Association of gut microbiota with idiopathic membranous nephropathy.

Authors:  Mengfei Li; Lixue Wei; Jing Sun; Qianshen Zhu; He Yang; Yu Zhang; Chao Zhang; Lin Xi; Rong Zhao; Xuanyi Du
Journal:  BMC Nephrol       Date:  2022-04-30       Impact factor: 2.585

Review 3.  Membranous nephropathy: Systems biology-based novel mechanism and traditional Chinese medicine therapy.

Authors:  Hua Miao; Yamei Zhang; Xiaoyong Yu; Liang Zou; Yingyong Zhao
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

4.  Gut Microbiome Analysis Can Be Used as a Noninvasive Diagnostic Tool and Plays an Essential Role in the Onset of Membranous Nephropathy.

Authors:  Jin Shang; Yiding Zhang; Ruixue Guo; Wenli Liu; Jun Zhang; Ge Yan; Feng Wu; Wen Cui; Peipei Wang; Xuejun Zheng; Ting Wang; Yijun Dong; Jing Zhao; Li Wang; Jing Xiao; Zhanzheng Zhao
Journal:  Adv Sci (Weinh)       Date:  2022-08-17       Impact factor: 17.521

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.